It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Approximately 20% of sleeping sickness patients exhibit respiratory complications, however, with a largely unknown role of the parasite. Here we show that tsetse fly-transmitted Trypanosoma brucei parasites rapidly and permanently colonize the lungs and occupy the extravascular spaces surrounding the blood vessels of the alveoli and bronchi. They are present as nests of multiplying parasites exhibiting close interactions with collagen and active secretion of extracellular vesicles. The local immune response shows a substantial increase of monocytes, macrophages, dendritic cells and γδ and activated αβ T cells and a later influx of neutrophils. Interestingly, parasite presence results in a significant reduction of B cells, eosinophils and natural killer cells. T. brucei infected mice show no infection-associated pulmonary dysfunction, mirroring the limited pulmonary clinical complications during sleeping sickness. However, the substantial reduction of the various immune cells may render individuals more susceptible to opportunistic infections, as evident by a co-infection experiment with respiratory syncytial virus. Collectively, these observations provide insights into a largely overlooked target organ, and may trigger new diagnostic and supportive therapeutic approaches for sleeping sickness.
A number of human African trypanosomiasis, or sleeping sickness, patients suffer from respiratory symptoms commonly attributed to cardiac insufficiency. Here, the authors characterise the role of pulmonary Trypanosoma brucei in respiratory infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Antwerp, Laboratory of Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, Wilrijk, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)
2 University of Antwerp, Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, Wilrijk, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)
3 Université libre de Bruxelles, Center for Microscopy and Molecular Imaging, Gosselies, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université libre de Bruxelles, Laboratory of Molecular Parasitology, IBMM, Gosselies, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746)
4 Slovak Academy of Sciences, Institute of Zoology, Bratislava, Slovakia (GRID:grid.419303.c) (ISNI:0000 0001 2180 9405); Scientica, Ltd., Bratislava, Slovakia (GRID:grid.455086.a)
5 Immunology and Transplantation, Rega Institute of Medical Research, KU Leuven, Clinical and Epidemiological Virology, Department of Microbiology, Leuven, Belgium (GRID:grid.415751.3)